Glia-Neuron Interactions in the Retina Can Be Studied in Cocultures of Muller Cells and Retinal Ganglion Cells by Skytt, D. M. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Glia-Neuron Interactions in the Retina Can Be Studied in Cocultures of Muller Cells and
Retinal Ganglion Cells
Skytt, D. M.; Toft-Kehler, A. K.; Braendstrup, C. T.; Cejvanovic, S; Gurubaran, I. S.;
Bergersen, L. H.; Kolko, M.
Published in:
Journal of Biomedicine and Biotechnology
DOI:
10.1155/2016/1087647
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Skytt, D. M., Toft-Kehler, A. K., Braendstrup, C. T., Cejvanovic, S., Gurubaran, I. S., Bergersen, L. H., & Kolko,
M. (2016). Glia-Neuron Interactions in the Retina Can Be Studied in Cocultures of Muller Cells and Retinal
Ganglion Cells. Journal of Biomedicine and Biotechnology, 2016, [1087647].
https://doi.org/10.1155/2016/1087647
Download date: 03. Feb. 2020
Research Article
Glia-Neuron Interactions in the Retina Can Be Studied in
Cocultures of Müller Cells and Retinal Ganglion Cells
D. M. Skytt,1 A. K. Toft-Kehler,1 C. T. Brændstrup,1 S. Cejvanovic,1
I. S. Gurubaran,1 L. H. Bergersen,1,2,3 and M. Kolko1,3,4
1Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen,
Blegdamsvej 3b, 2200 Copenhagen, Denmark
2Brain and Muscle Energy Group, Faculty of Dentistry, Institute of Oral Biology, University of Oslo, P.O. Box 1152, Blindern,
0316 Oslo, Norway
3Center of Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, 2200 Copenhagen, Denmark
4Zealand University Hospital, Department of Ophthalmology, Vestermarksvej 23, 4000 Roskilde, Denmark
Correspondence should be addressed to M. Kolko; mkolko@dadlnet.dk
Received 24 February 2016; Revised 27 April 2016; Accepted 19 May 2016
Academic Editor: Xu Wang
Copyright © 2016 D. M. Skytt et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Glia-neuron partnership is important for inner retinal homeostasis and any disturbances may result in retinal ganglion cell (RGC)
death.Mu¨ller cells support RGCswith essential functions such as removing excess glutamate and providing energy sources.The aim
was to explore the impact ofMu¨ller cells on RGC survival. To investigate theMu¨ller cell/RGC interactions we developed a coculture
model, in which primary Mu¨ller cells were grown in inserts on top of pure primary RGC cultures. The impact of starvation and
mitochondrial inhibition on the Mu¨ller cell ability to protect RGCs was studied. Moreover, the ability of Mu¨ller cells to remove
glutamate from the extracellular spacewas investigated. RGC survivalwas evaluated by cell viability assays and glutamate uptakewas
assessed by kinetic uptake assays. We demonstrated a significantly increased RGC survival in presence of untreated and prestarved
Mu¨ller cells. Additionally, prestarved Mu¨ller cells significantly increased RGC survival after mitochondrial inhibition. Finally, we
revealed a significantly increased ability to take up glutamate in starved Mu¨ller cells. Overall, our study confirms essential roles of
Mu¨ller cells in RGC survival. We suggest that targeting Mu¨ller cell function could have potential for future treatment strategies to
prevent blinding neurodegenerative retinal diseases.
1. Introduction
Interactions between the most inner retinal neurons, the
retinal ganglion cells (RGCs), and the most abundant retinal
glial cells, theMu¨ller cells, are essential to a functional retinal
homeostasis. Mu¨ller cells span the entire thickness of the
retina from the inner nerve fiber layer near the vitreous to
the outer segment near the retinal pigment epithelium. The
Mu¨ller cells are specialized radial glial cells and constitute
an anatomical and functional link between neurons and
the cellular environment such as blood vessels, the vitreous
chamber, and subretinal space. They play a pivotal role in
maintaining the structural integrity of the retina as well
as sustaining the retinal homeostasis by participating in
essential processes such as glucose metabolism, substrate
exchange, and vascular regulation [1, 2].
Virtually every aspect of inner retinal homeostasis and
function involves a glia-neuron partnership. Growing evi-
dence supports this particular interaction as being funda-
mental for different aspects of neurodegenerative retinal
diseases [2–4]. However, the present knowledge about the
partnership between RGCs and Mu¨ller cells is limited.
The pathological mechanisms of neurodegenerative diseases
in the retina are still being debated and there are vari-
ous hypotheses concerning the cause of the RGC death.
Particularly glutamate excitotoxicity [5–8], mitochondrial
dysfunction [9–12], oxidative stress [9, 13, 14], disturbed
energy metabolism [15–18], altered autoregulation [19, 20],
Hindawi Publishing Corporation
BioMed Research International
Volume 2016, Article ID 1087647, 10 pages
http://dx.doi.org/10.1155/2016/1087647
2 BioMed Research International
and finally sparse studies on disturbed Mu¨ller cell function
[3, 5, 15] are among the discussed precursors of RGC death.
The most abundant excitatory neurotransmitter in the
central nervous system, including the retina, is the amino
acid glutamate [21]. Glutamate is taken up by glutamate
transporters into the Mu¨ller cells and hence the glutamate
transporters are ultimately responsible for balancing the
extracellular glutamate level between physiological signalling
and pathological overactivation. In Mu¨ller cells the predom-
inant glutamate transporter is the excitatory amino acid
transporter 1 (EAAT1, also known as GLAST) [22, 23]. We
have previously reported that cell cultures of the human
Mu¨ller glia cell line, MIO-M1 [24], are capable of increasing
their glutamate uptake and their expression of EAAT1 during
starvation [15], thus indicating a regulatory mechanism to
prevent excitotoxicity of the RGCs.
Previous studies have reported improved survival of
RGCs cultured with retinal glia cells [5, 25–28]. To the best
of our knowledge there have been no studies examining the
consequences of energy starvation on the Mu¨ller cell ability
to promote RGC survival. Here, we describe a coculture
model to study the glia-neuron interaction. We explore the
effects of prestarvation and starvation on survival of primary
Mu¨ller cells and primary RGCs. Furthermore, we examine
the effect of starvation and mitochondrial inhibition on
primary Mu¨ller cell viability and primary RGC viability.
Finally, we investigate the capacity of glutamate uptake in
Mu¨ller cells during starvation.
Our study provides knowledge of interactions between
primary RGCs and primary Mu¨ller cells in a coculture
system. We show a significant increase in RGC survival
in presence of Mu¨ller cells. A significant Mu¨ller cell pro-
tection is found in both untreated cocultures as well as
in prestarved cocultures and in prestarved cocultures with
inhibited mitochondrial function. Finally, we demonstrate
an increased capacity of Mu¨ller cells to transport glutamate
during starvation. Overall, our study suggests a vital role of
Mu¨ller cells in the RGC survival.
2. Materials and Methods
2.1. Primary Cell Cultures. Primary Mu¨ller cells and primary
retinal ganglion cells were cultured from dissected retinas
of neonatal mice (C57Bl/6J, Charles River, Germany) at
postnatal day 6–8 or 5, respectively. The mice were sacrificed
by cervical dislocation and the eyes were enucleated into D-
PBS. Retinas were carefully dissected under a microscope
(Leica S4E).
2.2. RGC Purification. Cultures of primary RGCs were puri-
fied by sequential immunopanning as described by the
group of Professor Barres [29, 30]. Briefly, dissected retinas
were digested with papain at 37∘C for 45 minutes, which
was terminated by rinsing the cells in buffers containing
increasing concentrations of ovomucoid (20–40mg/mL).
Following a gentle trituration, the retinal cells were resus-
pended in panning buffer containing insulin (5𝜇g/mL),
filtered through a 20𝜇m nylon mesh, and then incubated
with rabbit anti-macrophage antibody (AIA51240, Accurate
Chemical, USA). Retinal cells were incubated sequentially
on three immunopanning dishes: the first two coated with
anti-rabbit secondary antibodies (goat anti-rabbit IgG, 611-
1102, Rockland, USA) and the third with a RGC specificThy-
1 antibody (LS-C14009, LifeSpan, USA). The Thy-1 plate was
rinsed multiple times with EBSS. RGCs were released from
the final panning dishwith trypsin (Sigma-Aldrich,USA) and
the trypsinization was terminated using Neurobasal medium
(12349-015,Gibco by Life Technologies,USA) containing 33%
fetal bovine serum (Biological Industries, Israel). RGCs were
plated at high density (150.000 cells/cm2) on poly-D-lysine
(10 𝜇L/mL, Sigma-Aldrich) and laminin (10 𝜇g/mL, Sigma-
Aldrich) coated cell culture plates (TPP, Switzerland). The
RGCs were kept in culture in a 37∘C humidified atmosphere
with 10% CO
2
for 6 days in ND-growth medium with
change of a third of the medium volume on the third day in
culture. The ND-growth culture medium is formulated from
Neurobasal medium mixed in equal amounts with DMEM
high-glucose medium (31966, Gibco) with addition of peni-
cillin (1000 units/mL), streptomycin (1000 𝜇g/mL), insulin
(0.5 𝜇g/mL), sodium pyruvate (1.5mM), 3,3󸀠,5-Triiodo-L-
thyronine (40 ng/mL), L-glutamine (3.7mM), B27 supple-
ment (1x, Gibco), and trace elements B (1x, Cellgro, USA).
The medium was supplemented with a Sato stock consisting
of transferrin (100 𝜇g/mL), BSA (100𝜇g/mL), progesterone
(0.63 ng/mL), putrescine (16 𝜇g/mL), and sodium selen-
ite (40 ng/𝜇L). Finally, we added NAC (5 𝜇g/mL), biotin
(10 ng/mL), BDNF (50 ng/mL, 248-BD-025, R&D Systems,
UK), CNTF (10 ng/mL, 257-NT-010, R&D Systems), FGFb
(10 ng/mL, PMG0034, Gibco), and forskolin (4,2 𝜇g/mL) to
the medium.
2.3. Mu¨ller Cell Purification. The Mu¨ller cells were cul-
tured essentially as described by Hicks and Courtois [31].
Briefly, the dissected retinas were incubated for 30 minutes
in DMEM (21885, Gibco) supplemented with collagenase
(65U/mL) and trypsin (0.25%). Afterwards, the cells were
rinsed twice in DMEM containing 10% fetal bovine serum
(Gibco) to terminate the digestion. The digested retinas were
mechanically dissociated by gentle trituration through a 14G
needle producing a suspension of tissue microaggregates
and single cells. Cells were seeded in tissue culture plates
or flasks (TPP) or on 0.4 𝜇m membrane inserts (Falcon,
USA) at a density of 0.6 retina/cm2. Cells were maintained
at 37∘C in a humidified atmosphere with 5% CO
2
cultured
in DMEM containing glucose (1.0 g/L), pyruvate (1mM), L-
alanyl-glutamine (3.97mM), supplemented with penicillin
(90Units/mL) and streptomycin (90𝜇g/mL), and 10% fetal
bovine serum (Gibco).The cells were kept in culture for 10–14
days with culture medium changed twice a week. Aggregates
and debris were removed by forcible resuspension ofmedium
onto the cell monolayer. Cell cultures of approximately 80–
90% confluency were used for experiments.
2.4. Immunocytochemistry. Immunocytochemistry was per-
formed on cultures of primary Mu¨ller cells cultured for 10
days on poly-D-lysine coated cover glass slides and primary
retinal ganglion cells cultured on poly-D-lysine/laminin
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coated cover glass slides for 6 days. The cells were normal
conditioned before the fixation. Briefly, the cells were fixed
with 4% paraformaldehyde for 20 minutes at room temper-
ature and the membranes were permeated using 0.02mol/L
glycine and 0.1% Triton-X-100 in PBS for 30 minutes at room
temperature. Unspecific binding sites were blocked using 3%
freshly diluted BSA (A8806, Sigma-Aldrich) for 1 hour at
4∘C. Cell cultures were immunostained using a primary anti-
body against either glutamine synthetase (GS, G2781, Sigma-
Aldrich, 1 : 200), excitatory amino acid transporter 1 (EAAT1,
AB416, Abcam, UK, 1 : 200), microtubule associated protein
2 (MAP2, M4403, Sigma-Aldrich, 1 : 500), or growth associ-
ated protein-43 (GAP-43, AB5220, Millipore, USA, 1 : 500)
combined with Alexa Fluor 488 (A11034, Invitrogen, USA)
or Texas Red (T862, Invitrogen) as secondary antibody. On
some slides nuclei were counterstainedwith 0.3𝜇mol/LDAPI
(D3571, Invitrogen) for 3 minutes. Negative controls were
treated without primary antibody. The slides were mounted
with fluorescent mounting medium (Dako, Denmark) and
sealedwith nail polish. ForRGCs, imageswere obtainedusing
an iMIC confocalmicroscope (Till Photonics, FEI, Germany)
equipped with appropriate filter settings for detecting DAPI,
CY2/Alexa488, and Texas Red/Alexa561/594. The iMIC was
equipped with the following objectives: ×20, numerical aper-
ture (NA) = 0.75. The images of the cell culture were stitched
together using the LA Stitch plug-in in Fiji software (version
1.47q, NIH, USA) to create an image of the entire culture. For
Mu¨ller cells, fluorescence microscopy was performed using
LEICA DMIL LED equipped with filter cubes (DAPI, GFP
ET, and TX2 ET) and Leica Application Suite V4. Pictures
were captured using Leica DFC420 C Digital Microscope
Camera and analysed using Photoshop CS6.
2.5. Experimental Incubations. Our study included different
types of media for different types of experiments. Mu¨ller
Cells. A DMEMmedium (A14430, Gibco) with a formulation
of amino acids and typical extracellular concentrations of
inorganic salts was used for incubations of monocultures
of Mu¨ller cells. In the control incubations the DMEM was
added 6mM glucose, 1mM pyruvate, and 2.5mM glutamine.
Prestarvation or starvation of Mu¨ller cells was performed by
incubation for 24 hours in the DMEM by omitting glucose,
pyruvate, and glutamine. All incubations of monocultures
with Mu¨ller cells were performed at 37∘C and 5% CO
2
.
RGCs. For monocultures of RGCs and cocultures of RGCs
and Mu¨ller cells, the control medium consisted of the ND-
growth medium detailed in the methods section above for
RGC culturing (containing 25mM glucose, 1.5mM pyruvate,
and 3.7mM glutamine). For the starvation experiments the
Neurobasal (05-0128DJ, Gibco) and DMEM (A14430, Gibco)
components of the ND-growth medium were replaced with
glucose-, pyruvate-, and glutamine-free alternatives with
otherwise identical compositions. All incubations involving
RGCs were at 37∘C and 10% CO
2
. To block mitochondrial
activity 10 𝜇M antimycin A was added to the incubation
medium.
2.6. LDH Toxicity Assays. Lactate dehydrogenase (LDH)
cell cytotoxicity kit (Takara Bio Inc., Japan) was used to
quantitatively assess cell survival. The medium was changed
and the cells were starved (in absence of glucose, glutamine,
and pyruvate), treated with 10 𝜇M antimycin A, or left
untreated (control) for 24 hours. Plates were centrifuged at
500 RPM for 10 minutes, and the supernatants were used
for LDH determination as a measure of cell viability. The
LDH yield participates in a coupled reaction that converts
yellow tetrazolium salts into a red formazan product, which
was measured as a 490 nm absorbance reading. Each LDH
analysis was performed in triplicate and corrected on single
sample/well basis and correlated to total cell death by Triton-
X in each sample/well.
2.7. MTT Viability Assay. As a second viability assay,
Mu¨ller cell survival was determined by the colorimetric
method, MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazoliumbromide),measuring the ability of viable cells
to reduce MTT to a purple formazan salt, which can be
measured at absorbance 560 nm. The Mu¨ller cell cultures
were incubated in either starvation DMEM or starvation
DMEM treated with 1mM glutamate or left untreated (con-
trol DMEM) for 24 hours. Subsequently, the cells were
incubated with 12mM MTT solution for one hour at 37∘C
and the cells were solubilized in 10% SDS and 0.01M HCl.
Eighteen hours later, the absorbance at 560 nmwasmeasured.
The background readings (blank wells with medium, MTT
solution, and solubilization buffer) were subtracted from the
absorbance readings of the treated wells to obtain an adjusted
absorbance reading representing cell viability. Finally, the
readings were divided by the adjusted absorbance readings
of untreated (control) cells to obtain a percentage of cell
survival.
2.8. Glutamate Uptake Assay. The kinetic characterization
of glutamate transport into the Mu¨ller cells was performed
as described in our previous study [15]. Primary Mu¨ller
cells were cultured in 24-well plates and cells were treated
with the relevant conditions for 24 hours. The cells were
preincubated for 3minutes at 37∘C inHBSS (HEPES buffered
saline solution; 142mMNaCl, 5mMKCl, 1mMCaCl
2
, 1 mM
MgCl
2
, 1 mM Na
2
HPO
4
, and 10mM HEPES) containing
different concentration of L-glutamate (range 1–500𝜇M).
Subsequently the Mu¨ller cells incubated for additionally
3 minutes in HBSS including trace amounts (1 : 200) of
L-[3,4-3H]-glutamate (4 𝜇Ci/mL, Perkin-Elmer, Waltham,
MA). The cellular content of radioactivity was determined
in cells extracted in KOH and analysed by liquid scintillation
counting in a Beckman LS6500 Liquid Scintillation Counter
(Beckman Coulter, USA). Uptake rates were corrected for
protein concentrations, which were measured in the cell
extracts using BCAprotein assay kit (Sigma-Aldrich). Unspe-
cific uptake was determined by incubation at 0∘C. Uptake
kinetics was assumed to follow the normalMichaelis-Menten
kinetics. The maximal uptake rate, 𝑉max, was determined
using a nonlinear regression in GraphPad Prism 6 (𝑦 = 𝑉max ⋅
𝑥/(𝐾
𝑚
+ 𝑥)).
2.9. Cocultures of RGCs and Mu¨ller Cells. To investigate the
glia-neuron interactions, cocultures of RGCs and Mu¨ller
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cells were established. Primary Mu¨ller cells were precultured
in Falcon 0.4 𝜇m membrane inserts (Corning, USA) for
9 days in the DMEM used for normal cell culturing as
described above. Likewise RGCs were cultured in coated 24-
well plates for 5 days as detailed previously.When assembling
the coculture, a complete medium change was performed
for both RGCs and Mu¨ller cells with ND-growth medium.
Subsequently, the inserts with Mu¨ller cells were placed
into the wells containing RGCs, and the cocultures were
maintained in a 37∘C humidified atmosphere with 10% CO
2
for 24 hours to examine cell viability following the conditions
detailed above. To measure cell viability in cocultures media
were collected for LDH analysis.
2.10. Statistical Analysis. All statistical analyses were per-
formed inGraphPad Prism 6.0 software (GraphPad Software,
USA) and 𝑃 values less than 0.05 were considered significant.
The sample size of each experiment (𝑛) has been determined
from either a triplicate or more. All data are expressed
as means ± SEM and differences between conditions were
analysed using unpaired two-tailed 𝑡 tests when comparing
two sets of data. If more groups of data were analysed,
one-way analysis of variance (ANOVA) followed by Tukey’s
multiple comparison test was performed.
3. Results
3.1. Characterization of Primary Cell Cultures. To positively
characterize the primary cell cultures as Mu¨ller cells and
RGCs we performed immunocytochemical staining. During
isolation of RGCs by the immunopanning technique we
found some variability of the RGC homogeneity and to
evaluate the purity of the isolation we performed immuno-
cytochemical staining of RGCs. The staining confirmed the
neuronal origin of the RGCs by demonstrating expression
of GAP-43 (green, Figure 1) surrounding all nuclei stained
with DAPI (blue, Figure 1). In contrast, the lack of GFAP
staining in the cultures confirmed the absence of reactive
macroglia. During some RGC preparations, we observed a
degree of contamination by other cell types in the RGC
cultures, probably from insufficient rinsing of the Thy-1
immunoplates. In such case, the prepared cells were dis-
charged. The immunofluorescence labelling confirmed the
expression of glutamine synthetase (GS) in the cytosol of the
Mu¨ller cells (Figure 2(a)), which in the retina is selectively
expressed in Mu¨ller cells [32]. The primary Mu¨ller cells also
stained positive for the major glutamate transporter EAAT1
(Figure 2(b)).
3.2. Starvation and Simultaneous Mitochondrial Inhibition
Decrease RGC and Mu¨ller Cell Survival. To evaluate the
cytotoxic effects of starvation and mitochondrial inhibition
by antimycin A on primary Mu¨ller cells and primary RGC
cultures, we measured LHD levels. A significant decrease in
RGC survival was found in response to 24 hours of starvation
(Figure 3(a); 70% survival, 𝑃 < 0.05). Simultaneous starva-
tion and exposure to antimycin A cause a more pronounced
RGC death (Figure 3(a); 25% survival, 𝑃 < 0.0001),
whereas RGC survival was unaltered in cells solely exposed
to antimycin A. A more significant and pronounced decrease
of Mu¨ller cell viability was found due 24 hours of starvation
(Figure 3(b); 42% survival, 𝑃 < 0.0001). As with RGCs,
Mu¨ller cell viability was further reduced during simultaneous
starvation and treatment with antimycin A (Figure 3(b); 13%
survival, 𝑃 < 0.0001). Antimycin A exposure did not affect
Mu¨ller cell viability in cells with sufficient energy supply.
3.3. Glutamate Increases Survival of Starved Mu¨ller Cells. A
significant decrease in Mu¨ller cell viability due to starva-
tion was confirmed using a MTT-based cell survival assay
(Figure 4; 22%, 𝑃 < 0.0001). By adding 1mM glutamate
the cytotoxic effect as a result of starvation was diminished
(22% versus 39%; 𝑃 < 0.05), albeit it remained significantly
reduced compared with the control (39%, 𝑃 < 0.0001).
3.4. Starvation Increases Glutamate Uptake in Primary Mu¨ller
Cells. To determine the influence of starvation on the glu-
tamate uptake into primary Mu¨ller cells, glutamate uptake
was analysed in response to 24 hours of starvation at 7
different extracellular concentrations of glutamate from 1𝜇M
to 500 𝜇M. Our study revealed a significantly increased and
consistent uptake of glutamate throughout the experiment in
particular at extracellular glutamate concentrations of 10, 25,
and 100 𝜇M glutamate (Figure 5(a); 𝑃 < 0.05 and 𝑃 < 0.01).
Moreover, the relative 𝑉max was significantly increased upon
starvation (𝑃 < 0.05, Figure 5(b)).
3.5. Cocultures to Study Glia-Neuron Interaction. RGCs were
cultured in wells including an insert membrane containing
primary Mu¨ller cells in close proximity, yet without anatom-
ical contact. During this condition we found a significant
impact on RGC survival in wells grown with Mu¨ller cells
compared to RGCs cultured with an empty membrane
insert (Figure 6(a); 1.3-fold, 𝑃 < 0.05). When prestarving
the Mu¨ller cells for 24 hours, we demonstrated significant
increase of RGC survival after coculturing for 24 hours
(Figure 6(b); 1.4-fold, 𝑃 < 0.01). Moreover, we demon-
strated a tendency towards an increased survival of RGCs
in response to starvation (Figure 6(c); 1.2-fold, 𝑃 = 0.099).
To evaluate the effect of Mu¨ller cells on RGC survival when
mitochondrial functions were compromised, we cultured
RGCs and Mu¨ller cells in presence of antimycin A. During
compromised mitochondrial function, the Mu¨ller cells had
significant impact on the RGC survival due to 24 hours of
prestarvation (Figure 7(b); 1.4-fold, 𝑃 < 0.05). We found no
protective effect of Mu¨ller cells on RGC survival in cells with
sufficient energy availability after exposure to antimycin A.
Similarly, no increased RGC survival was seen in starved cells
exposed to antimycin A (Figures 7(a) and 7(c), resp.).
4. Discussion
RGC loss is a consequence of a variety of neurodegenerative
diseases in the retina. Among themost commonneurodegen-
erative retinal diseases are glaucoma and diabetic retinopathy
[33–35]. Glaucoma is the most common cause of irreversible
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MergeGAP-43
GFAPDAPI
Figure 1: Immunocytochemical staining of primary mouse RGCs.The purity of the primary RGCs was verified by positive immunostaining
with GAP-43 (green) surrounding nuclei stained withDAPI (blue).TheRGCs lackedGFAP (red) staining confirming the absence of activated
macroglial cells in the culture. Scale bars represent 100 𝜇M.
GS
(a)
EAAT1
(b)
Figure 2: Immunocytochemical staining of primary mouse Mu¨ller cells. Primary Mu¨ller cells positively expressed the Mu¨ller cell specific
marker, glutamine synthetase (GS) (GS green and DAPI stained nuclei blue, (a)). In addition, Mu¨ller cells expressed the glial cell specific
glutamate transporter EAAT1 (EAAT1 green, (b)). All scale bars represent 100 𝜇M.
blindness [36, 37]. It encompasses several conditions that all
lead to progressive loss of RGCs and their axons [38].Diabetic
retinopathy is another blinding disease caused by damage and
visual loss [35]. Most neurodegenerative retinal diseases are
age-dependent and the burden is increasing due to an aging
population [36, 37]. In this matter, neuroprotective strategies
have been increasingly studied [37]. No current strategies
have shown promise yet. Since RGCs remain unmyelinated
and are protected only by the surrounding macroglial cells, it
has been suggested that glia-neuron partnership is essential
for RGC survival. However, only limited evidence exists
on glia-neuron interactions in the retina. One of the first
contemporary studies to present glia-neuron interplay was
performed by Turner and Cepko [39]. The study proposed
that Mu¨ller cells perform many of the metabolic, ionic,
and extracellular buffering requirements of neurons [39]. In
the following years, an interesting concept of cooperability
between retinal neurons and Mu¨ller cells was proposed by
Reichenbach et al. [40]. Additional studies reported impor-
tant roles of Mu¨ller cells in transporting energy sources from
the vessels to the neurons [41] as well as removing glutamate
from the extracellular space by uptake carriers [42]. Another
implication of the importance of glia-neuron interaction is
the secretion of factors that favor neuronal survival byMu¨ller
cells [43].
In present study, we emphasize the importance of this
cellular relationship by coculturing primary RGCs with pri-
mary Mu¨ller cells. Furthermore, we aimed to investigate the
consequences of starvation and inhibition of mitochondrial
function by antimycin A on these cocultures. It is well
established that hypoglycemia may lead to retinal neuronal
loss in vitro [16–18]. The association between mitochondrial
6 BioMed Research International
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Figure 3: Cell viability of primary RGCs and primary Mu¨ller cells in response to starvation and mitochondrial inhibition. By means of LDH
assays, starvation for 24 hours was shown to decrease RGC survival significantly to 70% ((a); ∗𝑃 < 0.05, ∗∗𝑃 < 0.01) compared to control.
Likewise, starvation of Mu¨ller cells significantly decreased their survival to 42% of control ((b); ∗∗∗∗𝑃 < 0.0001). Mitochondrial inhibition by
exposure to 10 𝜇Mantimycin A did not affect RGC andMu¨ller cell survival ((a) and (b), resp.), whereas simultaneous starvation and exposure
to antimycin A significantly reduced RGC andMu¨ller cell survival to 25% and 13%, respectively ((a) and (b); ∗∗∗∗𝑃 < 0.0001). Bars represent
mean values ± SEM of 5–8 experiments. Differences in survival were tested using one-way ANOVA followed by Tukey’s multiple comparisons
test.
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Figure 4: Cell viability of primary Mu¨ller cells in response to
starvation and treatment with glutamate. By means of MTT assays
survival of starved Mu¨ller cells significantly decreased to 22%
(∗∗∗∗𝑃 < 0.0001) compared with control. Additional treatment
with 1mM glutamate in combination with starvation also reduced
the Mu¨ller cell viability to 39% (∗∗∗∗𝑃 < 0.0001). Nevertheless,
treatment with glutamate enhanced Mu¨ller survival significantly
compared to solely starved Mu¨ller cells (∗𝑃 < 0.05). The bars
represent mean values ± SEM of 3 experiments. Differences in
survival were tested using one-way ANOVA followed by Tukey’s
multiple comparisons test.
dysfunction and glaucoma has been reviewed [11, 44] and
oxidative stress as a result of mitochondrial impairment
has been connected to glaucomatous damage for several
years [14]. We demonstrate that Mu¨ller cells increase RGC
survival significantly during normal conditions and during
starvation as well as prestarvation. Moreover, the presence
of prestarved Mu¨ller cells promotes RGC survival during
inhibited mitochondrial function. Since starvation causes
decreased RGC and Mu¨ller cell survival the simultaneous
increased ability of Mu¨ller cells to take up glutamate may
indicate a protective mechanism that prevents glutamate-
induced excitotoxicity. Altogether, our coculture model of
primary RGCs and Mu¨ller cells confirms important roles of
Mu¨ller cells in RGC survival. Previous studies have examined
similar glia-neuron interactions. Furuya et al. demonstrated
an increased survival rate in a coculture model of primary
RGCs and Mu¨ller cells [27]. Moreover, Kawasaki et al. found
a protective effect of primary Mu¨ller cells against glutamate
excitotoxicity on primary RGCs [5]. A study by Matteucci
et al. described Mu¨ller cell protection of RGCs against high-
glucose conditions [28]. In fairness one study by Kashiwagi et
al. showed opposite decreased RGC survival when cocultured
with Mu¨ller cells [25]. All of the above-mentioned studies
were performed with cell cultures originating from rats. To
the best of our knowledge the present study is the first to
describe the supporting role of Mu¨ller cells in RGC survival
in primary cell cultures from mice as well as during pro-
longed starvation andmitochondrial inhibition, although the
precise mechanism still needs elucidation. Previous studies
examined the effect of various neurotrophic factors on RGC
survival [30], including brain-derived neurotrophic factor
(BDNF), which is produced byMu¨ller cells in the retina [45].
BDNF is assumed to affect the survival of RGCs [46] and
BDNF has been shown to upregulate GLAST and GS and
furthermore to increase the glutamate uptake during hypoxia,
of which the latter may accentuate the neuroprotective effects
[47]. Pigment-epithelium-derived factor (PEDF) secreted by
Mu¨ller cells is also contributing to the neuroprotective feature
of Mu¨ller cells towards RGC survival [48]. An intravitreal
PEDF transfection in a mouse model of glaucoma (DBA/2J
mice) resulted in reduced loss of RGCs and the total nerve
fiber layer, delayed vision loss, and reduced GFAP expression
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Figure 6: Mu¨ller cells increase RGC survival in cocultures. Importance of presence of Mu¨ller cells for RGC survival was investigated by
coculturing of the primary cell cultures. The presence of energy sufficient Mu¨ller cells for 24 hours significantly increased RGC survival by
1.3-fold ((a); ∗𝑃 < 0.05). A slightly increased RGC survival was found whenMu¨ller cells were prestarved for 24 hours before being inserted on
top of the RGCs. In this condition the survival rate increased to 1.4-fold upon 24 hours of coculture ((b); ∗∗𝑃 < 0.01). Finally, simultaneous
starvation of RGCs and Mu¨ller cells in cocultures resulted in a tendency towards increased RGC survival ((c); 1.2-fold, 𝑃 = 0.099). Bars
represent mean values ± SEM of 4–9 experiments. Differences were tested using unpaired two-tailed 𝑡-test.
in the retina and optic nerve [49]. Ciliary neurotrophic factor
(CNTF) has also been demonstrated to increase RGC survival
after injury [46, 50]. Despite the fact that CNTF is not
secreted by Mu¨ller cells, it has been suggested to modulate
retinal glial cells into a more neuroprotective phenotype,
which among others is characterized by a more efficient
buffering of high concentrations of glutamate [51].
The glia-neuron partnership includes a range of decisive
elements for the RGC homeostasis. Among these is the
glutamate-glutamine cycle. In recent years, the focus on
excitotoxicity [52, 53] has shifted from neuronal responses
to glial regulations and responses to glutamate. Here, we
demonstrate that Mu¨ller cells significantly increase their
ability to take up glutamate during starvation. This finding
extends our previous findings in the Mu¨ller cell line, MIO-
M1, showing a similar increase in glutamate uptake during
starvation [15]. However, we recently published a study
demonstrating a diminished function of the glutamate uptake
in Mu¨ller cells during simultaneous starvation and oxidative
stress. These observations indicate a disturbed Mu¨ller cells
homeostasis in presence of more than one environmental
stressor [54]. Our coculture system provides a model to
study glia-neuron interactions by permitting quantitative
assessment of the effects of different stimuli on glial cells and
neurons separately. Future implications of this system could
allow manipulation of gene expression on only one cell type
to enlighten the importance of specific proteins in the glia-
neuron interplay.
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Figure 7: Prestarved Mu¨ller cells promote RGC survival during mitochondrial inhibition. RGC survival was analysed in cocultures with
exposure to antimycin A (10𝜇M) for 24 hours. During compromised mitochondrial function, the presence of Mu¨ller cells had a significant
impact on RGC survival when the Mu¨ller cells were prestarved ((b); 1.4-fold, ∗𝑃 < 0.05). The experiment showed no alterations of RGC
survival in cocultures with sufficient energy supply (a) nor in cocultures with simultaneous starvation and treatment with antimycin A (c).
Bars represent mean values ± SEM of 3–9 experiments. Differences were tested using unpaired two-tailed 𝑡-test.
The effects of 24 hours of starvation were evaluated by
cell viability assays and surprisingly the experiments revealed
greater vulnerability of Mu¨ller cells compared to RGCs.
This observation indicates a greater robustness of RGCs to
environmental stress such as starvation. This could be due
to a more complex formulation of the ND-growth medium
used for RGCs, whereas DMEM used for Mu¨ller cell cultures
were not supplemented with various neurotrophic factors.
Winkler et al. previously examined the viability of Mu¨ller
cells upon 4 hours of starvation and the study showed a
resistance ofMu¨ller cells to this relatively transient starvation
[55]. A study byWood et al. using a mixed retinal cell culture
did indeed demonstrate that glial cells require a supply of
glucose for survival in a culture upon 36 hours of starvation
[56].The sensibility ofMu¨ller cells upon starvation prompted
us to analyse the Mu¨ller cell viability using another cell
viability assay. Through MTT viability assays, the Mu¨ller
cell viability was even further reduced due to 24 hours of
starvation (Figure 4). Interestingly, the addition of glutamate
to the starvation medium significantly increased the Mu¨ller
cell survival indicating a capability ofMu¨ller cells to consume
glutamate as an energy substrate. The oxidative metabolism
of glutamate has been well described in brain astrocytes both
in vitro and in vivo [57–59]. On the contrary, the use of
glutamate as an energy substrate is less described in Mu¨ller
cells [41, 60]. Additionally, the vulnerability of Mu¨ller cells
due to starvation potentially suggests a further increase of
glutamate uptake intoMu¨ller cell than the uptake experiment
might indicate (Figure 5(a)). The uptake experiment was
corrected for mg protein and therefore the correction does
not necessarily reflect viable cells with a functional glutamate
uptake.
In conclusion we show that Mu¨ller cells promote RGC
survival independently of anatomical interaction. Hence,
secreted factors as well as increased removal of excess
extracellular glutamate may be essential in RGC-Mu¨ller cell
interactions. Overall, our study indicates essential roles of
Mu¨ller cells in RGC-related neurodegenerative conditions.
Strategies aiming at regulating the homeostasis ofMu¨ller cells
might prove useful in preventing RGC loss. Current studies
in our laboratory are addressing glucose and glutamate
metabolism within Mu¨ller cells in greater details. Future
studies are necessary to further assess the potential of Mu¨ller
cells as pharmacological targets in treatment strategies of
RGC-related inner retinal conditions.
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